Live Quote · NASDAQPCSAHealthcare· Biotechnology

Processa Pharmaceuticals, Inc.

$1.56▼ 7.69%($-0.13)
MKT CAP $4.37MNEXT EARNINGS Mar 3, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
95
Valuation
20
Profitability
60
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCSA research report →

Analyst Price Target
$225.00+14323.1% vs. today

Range $225 – $225

Analyst RatingBuy
4 Buy1 Hold0 Sell

Price Chart

-77.09% · this period
$7.62$4.49$1.35Nov 20May 26Nov 20
52-Week Range7% of range
Low
$1.04
Current
$1.56
High
$8.88